Research And Development Expense Reversal Excluding Acquired In Process Cost

Name: AnaptysBio, Inc. Research And Development Expense Reversal Excluding Acquired In Process Cost by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

AnaptysBio, Inc.·Products & Services·8 segments

Breakdown

Segment	Q1 '26
External Expenses	$18.66M
Internal Expenses	$15.33M
ANB033	$9.3M
Rosnilimab	$4.59M
Preclinical And Other Unallocated Costs	$3.3M
ANB101	$1.48M
ANB032	-$31K
Imsidolimab	$21K
Total	-$31K

Segments

ANB032View metric

ANB033View metric

ANB101View metric

External ExpensesView metric

ImsidolimabView metric

Internal ExpensesView metric

Preclinical And Other Unallocated CostsView metric

RosnilimabView metric